MEDICAL HYPOTHESES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2020-02-02 94820d49m暂无昵称

审稿速度:1.0 | 投稿命中率:50.0
经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試

293 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2015-02-16 b2007117

我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了

475 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2022-06-28 ms2000001076054986

这个杂志就是扯淡，结论全是假设

56 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2021-12-29 衣谷

期刊可以有几个通讯作者/第一作者？

68 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2020-11-30 1239e854m65暂无昵称

写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。

132 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2020-06-29 1239e854m65暂无昵称

审稿速度:1.0 | 投稿命中率:75.0
经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了

160 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2018-07-15 shaworld

审稿速度:6.0 | 投稿命中率:50.0
经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯

317 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2021-12-27 rayms

什么是correspondingauthor/通讯作者？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2020-09-15 1239e854m65暂无昵称

投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。

144 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=584143, encodeId=b227584143d2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：把國外實驗室暑期實習的資料整理了一下，2019年11月底投稿，五天後送review，major revision一次後於2020年一月底接受，處理速度快，提出的問題也都中肯，適合初出茅廬的本科生嘗試, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=799a5270695, createdName=94820d49m暂无昵称, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509913, encodeId=131450991308, content=我的一位师兄在此发了四五篇文章，我也投了一篇，说和杂志不是很相关，建议投她的姊妹刊，非SCI，后来改投其他，接受发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 16 10:20:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229130, encodeId=1e181229130b6, content=这个杂志就是扯淡，结论全是假设, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jun 28 12:28:29 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095354, encodeId=504810953541c, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903661, encodeId=56029036610d, content=写了一篇关于新冠肺炎治疗的假说，竟然告诉我不适合这本期刊，建议我投转化医学杂志。。大家有遇到类似问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Nov 30 21:39:10 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800327, encodeId=606080032e61, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：涨了，涨到1.375。怎么才能突破2分啊？感觉太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Mon Jun 29 19:18:05 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559222, encodeId=bfdf55922231, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：求编辑部编辑的联系邮箱，在EVISE系统投稿四个月，一直是under review,通过系统给编辑发了好几封邮件，一直都没人回，感觉直接被遗忘了，不管状态如何，起码也得回复一下邮件吧，我发了4封了，一直没有音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=307c2083967, createdName=shaworld, createdTime=Sun Jul 15 11:45:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095353, encodeId=a6e0109535331, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885343, encodeId=17f08853438d, content=投稿一次关于干细胞，两三天后说要更改格式，一周后直接被拒。理由是不符合投稿范围，建议投转化医学。这是什么神操作。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqmibYgzhSR2S25HhtniaUZQsh91ib46tMaZuh9JGEgSNhowOCoJkfhm9iaYSk9KJEcDAXGrxoIkDE8mg/132, createdBy=08002423250, createdName=1239e854m65暂无昵称, createdTime=Tue Sep 15 06:54:48 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186384, encodeId=e344218638493, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：医学假说 经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd56475295, createdName=ms7000000095997590, createdTime=Wed Feb 07 20:09:06 CST 2024, time=2024-02-07, status=1, ipAttribution=广东省)]

2024-02-07 ms7000000095997590 来自广东省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：医学假说
经验分享：投了一篇评论，投了就忘了，1个多月突然收到接收，如果不着急，可以投着玩

17 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务